Form D · Pharmaceuticals

CALISTOGA PHARMACEUTICALS INC

Seattle, WA · CIK 0001385313

Offering snapshot reported Dec 27, 2010 · SEC filing

Reported sold
$25M
Offering amount: $50M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 29, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12.5M$25MJul 2, 2010: $19,281,219.00Jul 2, 2010Dec 27, 2010: $24,999,990.00Dec 27, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$19,281,219 → $24,999,990
  • Reported investors13 → 17

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 27, 2010Amendment$24,999,990$5,718,771vs Jul 2, 201017SEC filing
Jul 2, 2010Initial$19,281,219No comparison13SEC filing
May 14, 2009Initial$14,999,999No comparisonNot reportedSEC filing
Mar 17, 2009Initial$1,000,000No comparisonNot reportedSEC filing
Dec 27, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Dec 15, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-144409

Source: Form D, filed Dec 27, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Aaron Coe Executive
Robert Lee Douglas Director
Carol Gallagher Director, Executive
W. Michael Gallatin Director, Executive
W. Michael Gallatin Director, Promoter
Andrew Guggenhime Executive
Ed Hurwitz Director
Edward Hurwitz Director
Richard Lin Director
Langdon Miller Executive
Clifford Stocks Executive
James Topper Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2101 Fourth Avenue Suite 1960
Seattle, WA, 98121